Company: DMAAR
Filing Date: 2025-01-14
Form Type: POS AM
Source: 0001213900-25-003137
Chunk: 26

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-14
Form: POS AM
Chunk 26
---
 the sponsor, the private placement units allocated to it in connection with the closing of this offering, the sponsor will issue membership interests at a nominal purchase price to the non -managingsponsor investors at the closing of this offering reflecting interests in an aggregate of 666,667 founder shares held by the sponsor. None of the non -managingsponsor investors has expressed to us an interest in purchasing more than 9.9% of the units to be sold in this offering, except one non -managingsponsor investor has expressed to us an interest in purchasing 19.9% of the units to be sold in this offering; •“ordinary shares” are to our ordinary shares, par value $0.0001 per share; 11 •“private units” are to the units issued to our sponsor in a private placement simultaneously with the closing of this offering, as well as any units that may be issued upon conversion of working capital loans, each unit consisting of one ordinary share and one right to receive one -eighth(1/8) of an ordinary share upon the consummation of an initial business combination; “private shares” refer to the shares included in the private units as well as any shares included in the units that may be issued upon conversion of working capital loans; and “private rights” refer to the rights included in the private units as well as any rights included in the units that may be issued upon conversion of working capital loans; •“public rights” are to the rights sold as part of the units in this offering (whether they are purchased in this offering or thereafter in the open market); •“public shares” are to the ordinary shares sold as part of the units in this offering (whether they are purchased in this offering or thereafter in the open market); •“public shareholders” are to the holders of our public shares, including our initial shareholders, directors, officers and any non -managingsponsor investors to the extent our initial shareholders, directors, officers or any non -managingsponsor investor purchase public shares, provided their status as a “public shareholder” shall only exist with respect to such public shares; •“rights” are to the rights sold as part of the units in this offering and the private placement (whether they are purchased in this offering or thereafter in the open market), which include the public rights as well as the private rights; and •“sponsor” are to Drugs Made In America Acquisition LLC, a Delaware limited liability company; Lynn Stockwell is the managing member of